Aiwu Ruth He, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC) (NCT04541173) | Aiwu Ruth He, MD | 2020-11-30 |
Track Aiwu Ruth He, MD automatically
Every clearance here is in the API, with alerts when new ones post.